TMF merger and acquisitions (M&A) support

In today’s pharmaceutical M&A environment, products or assets that have been through clinical development – sometimes years previously – often end up with new owners. And while the science and market rationale behind these acquisitions are the focus, much less attention is paid to an important practical question: What is the state of the Trial Master File?

Thanks to our industry-leading TMF expertise and our mastery of eTMF technologies, you can now easily get a true picture of your acquired product or asset’s readiness for inspection and/or submission.  Whether you’ve received hundreds of boxes of paper documents, terabytes of data, or some combination, we are recognized as the leader in rapidly and accurately converting this often chaotic documentation into a high-quality, inspection-ready TMF.